Evidence map›Paper›PMID 26550577›Full record

ArticleBioMed research international2015

Glutamine may repress the weak LPS and enhance the strong heat shock induction of monocyte and lymphocyte HSP72 proteins but may not modulate the HSP72 mRNA in patients with sepsis or trauma.

Efrossini Briassouli, Marianna Tzanoudaki, Dimitris Goukos, Christina Routsi, Serafim Nanas, Kostas Vardas, Kleovoulos Apostolou, Maria Kanariou, George Daikos, George Briassoulis

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Efrossini BriassouliFirst Department of Propaedeutic Internal Medicine, University of Athens, Athens, Greece.
Marianna TzanoudakiDepartment of Immunology-Histocompatibility, Specialized Center & Referral Center for Primary Immunodeficiencies-Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece.
Dimitris GoukosFirst Department of Propaedeutic Internal Medicine, University of Athens, Athens, Greece.
Christina RoutsiFirst Critical Care Department, Evangelismos Hospital, University of Athens, Athens, Greece.
Serafim NanasFirst Critical Care Department, Evangelismos Hospital, University of Athens, Athens, Greece.
Kostas VardasFirst Critical Care Department, Evangelismos Hospital, University of Athens, Athens, Greece.
Kleovoulos ApostolouFirst Critical Care Department, Evangelismos Hospital, University of Athens, Athens, Greece.
Maria KanariouDepartment of Immunology-Histocompatibility, Specialized Center & Referral Center for Primary Immunodeficiencies-Paediatric Immunology, "Aghia Sophia" Children's Hospital, Athens, Greece.
George DaikosFirst Department of Propaedeutic Internal Medicine, University of Athens, Athens, Greece.
George BriassoulisPediatric Intensive Care Unit, University Hospital, University of Crete, 71500 Heraklion, Greece.
National and Kapodistrian University of Athens · GRChildren's Hospital Agia Sophia · GRUniversity of Crete · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe assessed the lipopolysaccharide (LPS) or heat shock (HS) induction of heat shock protein-72 (HSP72) in peripheral blood mononuclear cells (PBMCs) of patients with severe sepsis (SS) or trauma-related systemic inflammatory response syndrome (SIRS), compared to healthy individuals (H); we also investigated any pre- or posttreatment modulating glutamine (Gln) effect.

methodsSS (11), SIRS (10), and H (19) PBMCs were incubated with 1 μg/mL LPS or 43°HS. Gln 10 mM was either added 1 h before or 1 h after induction or was not added at all. We measured monocyte (m), lymphocyte (l), mRNA HSP72, HSP72 polymorphisms, interleukins (ILs), monocyte chemoattractant protein-1 (MCP-1), and cortisol levels.

resultsBaseline lHSP72 was higher in SS (p < 0.03), and mHSP72 in SIRS (p < 0.02), compared to H. Only HS induced l/mHSP72/mRNA HSP72; LPS induced IL-6, IL-8, IL-10, and MCP-1. Induced mRNA was related to l/mHSP72, and was related negatively to cytokines. Intracellular l/mHSP72/HSP72 mRNA was related to serum ILs, not being influenced by cortisol, illness severity, and HSP72 polymorphisms. Gln did not induce mRNA in any group but modified l/mHSP72 after LPS/HS induction unpredictably.

conclusionsHSP72 mRNA and l/mHSP72 are higher among critically ill patients, further induced by HS, not by LPS. HSP72 proteins and HSP72 mRNA are related to serum ILs and are negatively related to supernatant cytokines, not being influenced by HSP72 polymorphisms, cortisol, or illness severity. Gln may depress l/mHSP72 after LPS exposure and enhance them after HS induction, but it may not affect early induced HSP72 mRNA.

Indexed as

Cells, CulturedDose-Response Relationship, DrugGlutamineHeat-Shock ResponseHSP72 Heat-Shock ProteinsHumansLipopolysaccharidesLymphocytesMonocytesRNA, MessengerSepsisSystemic Inflammatory Response SyndromeWounds and InjuriesGlutamineHSP72 Heat-Shock ProteinsLipopolysaccharidesRNA, Messenger

Identifiers

PMID26550577
PMCPMC4621332
OpenAlexW2161471565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.